arrow
Y

Y.L. Verschoor

Netherlands Cancer Institute
H指数:9
被引数:1,002

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neoadjuvant immunotherapy in mismatch-repair-proficient colon cancers

错配修复功能 proficient 结直肠癌的新辅助免疫疗法

Nature
IF48.5
2025-10-200
PRE
Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial
2024-09-150
OAAI
Neoadjuvant immunotherapy in locally advanced MMR-deficient colon cancer: 3-year disease-free survival from NICHE-2

局部晚期MMR-deficient结肠癌的新辅助免疫疗法:NICHE-2研究3年无病生存率

2024-09-013
PRE
Neoadjuvant nivolumab (nivo) plus relatlimab (rela) in MMR-deficient colon cancer: Results of the NICHE-3 study

新辅助纳武利尤单抗(nivo)联合雷利利尤单抗(rela)在微卫星不稳定性高结肠癌中的研究:NICHE-3研究的结果

2024-09-012
PRE
Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair-Deficient Colon Cancer
2024-06-0634
PRE
Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial
2024-03-061
OAAI
Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial

新辅助阿特珠单抗联合化疗治疗胃和胃食管交界处腺癌: 2期熊猫试验

2024-01-0830
OAAI